Home›Companies›Biotech & Pharma›Radiance Biopharma

Radiance Biopharma, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 28, 2024·Suggest an edit

About Radiance Biopharma

Radiance Biopharma is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $250,000 raised in one offering on Form D since February 2024. Its chief executive is Robert Brooks.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 13, 2024Feb 28, 2024$250,000of $30.0M target1$250KDebt, Options, Convertible Promissory Note.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Radiance Biopharma's Form D filed Feb 28, 2024.

RB
Robert Brooks
Chief Executive Officer and director
ML
Marc Lippman
Executive officer and director

Sources

  1. SECRadiance Biopharma, Inc. filing history